Dominique Charmot

3.0k total citations
66 papers, 2.6k citations indexed

About

Dominique Charmot is a scholar working on Immunology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Dominique Charmot has authored 66 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Immunology, 14 papers in Organic Chemistry and 14 papers in Molecular Biology. Recurrent topics in Dominique Charmot's work include T-cell and B-cell Immunology (27 papers), Immunotherapy and Immune Responses (18 papers) and Immune Cell Function and Interaction (15 papers). Dominique Charmot is often cited by papers focused on T-cell and B-cell Immunology (27 papers), Immunotherapy and Immune Responses (18 papers) and Immune Cell Function and Interaction (15 papers). Dominique Charmot collaborates with scholars based in France, United States and Spain. Dominique Charmot's co-authors include Claude Mawas, Samir Z. Zard, José M. Asúa, Christophe Plessis, Harold A. S. Schoonbrood, José R. Leiza, Gurutze Arzamendi, Mathias Destarac, Stephen Shaw and Ghenwa Bouhadir and has published in prestigious journals such as Nature, The EMBO Journal and The Journal of Immunology.

In The Last Decade

Dominique Charmot

65 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dominique Charmot France 24 1.1k 650 366 308 267 66 2.6k
T. van Es United States 13 610 0.6× 158 0.2× 1.2k 3.4× 142 0.5× 165 0.6× 23 2.6k
Thomas Mueller Germany 34 576 0.5× 181 0.3× 1.0k 2.8× 107 0.3× 187 0.7× 113 3.1k
Hiroyasu Ishida Japan 20 188 0.2× 232 0.4× 635 1.7× 121 0.4× 240 0.9× 72 1.4k
Su He Wang United States 24 140 0.1× 293 0.5× 633 1.7× 374 1.2× 324 1.2× 45 1.8k
Charles J. McDonald United States 21 210 0.2× 329 0.5× 382 1.0× 89 0.3× 172 0.6× 63 1.7k
Yugang Liu China 34 631 0.6× 600 0.9× 996 2.7× 35 0.1× 255 1.0× 108 3.1k
Hamidreza Montazeri Aliabadi United States 24 380 0.4× 179 0.3× 1.1k 3.0× 147 0.5× 145 0.5× 64 2.4k
Adam W. G. Alani United States 26 271 0.3× 187 0.3× 716 2.0× 113 0.4× 198 0.7× 53 2.3k
Akemi Ryu Japan 13 451 0.4× 1.1k 1.7× 533 1.5× 77 0.3× 591 2.2× 19 2.6k
Hong Zong China 26 207 0.2× 174 0.3× 915 2.5× 298 1.0× 293 1.1× 98 1.8k

Countries citing papers authored by Dominique Charmot

Since Specialization
Citations

This map shows the geographic impact of Dominique Charmot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dominique Charmot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dominique Charmot more than expected).

Fields of papers citing papers by Dominique Charmot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dominique Charmot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dominique Charmot. The network helps show where Dominique Charmot may publish in the future.

Co-authorship network of co-authors of Dominique Charmot

This figure shows the co-authorship network connecting the top 25 collaborators of Dominique Charmot. A scholar is included among the top collaborators of Dominique Charmot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dominique Charmot. Dominique Charmot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jacobs, Jeffrey, Michael R. Leadbetter, Noah Bell, et al.. (2022). Discovery of Tenapanor: A First-in-Class Minimally Systemic Inhibitor of Intestinal Na+/H+ Exchanger Isoform 3. ACS Medicinal Chemistry Letters. 13(7). 1043–1051. 14 indexed citations
2.
Chen, Tao, Noah Bell, Patricia D. Finn, et al.. (2018). Design of Gut-Restricted Thiazolidine Agonists of G Protein-Coupled Bile Acid Receptor 1 (GPBAR1, TGR5). Journal of Medicinal Chemistry. 61(17). 7589–7613. 28 indexed citations
3.
Johansson, Susanne, Maria Leonsson‐Zachrisson, Mikael Knutsson, et al.. (2016). Preclinical and Healthy Volunteer Studies of Potential Drug–Drug Interactions Between Tenapanor and Phosphate Binders. Clinical Pharmacology in Drug Development. 6(5). 448–456. 16 indexed citations
4.
Labonté, Eric D., Christopher W. Carreras, Michael R. Leadbetter, et al.. (2014). Gastrointestinal Inhibition of Sodium-Hydrogen Exchanger 3 Reduces Phosphorus Absorption and Protects against Vascular Calcification in CKD. Journal of the American Society of Nephrology. 26(5). 1138–1149. 86 indexed citations
5.
Spencer, Andrew, Eric D. Labonté, David P. Rosenbaum, et al.. (2014). Intestinal Inhibition of the Na + /H + Exchanger 3 Prevents Cardiorenal Damage in Rats and Inhibits Na + Uptake in Humans. Science Translational Medicine. 6(227). 227ra36–227ra36. 126 indexed citations
6.
Charmot, Dominique. (2012). Non-Systemic Drugs: A Critical Review. Current Pharmaceutical Design. 18(10). 1434–1445. 64 indexed citations
7.
Cope, M., Jing Shao, Erol Göka, et al.. (2009). The phospholipase A2 inhibitor methyl indoxam suppresses diet‐induced obesity and glucose intolerance in mice. British Journal of Pharmacology. 157(7). 1263–1269. 45 indexed citations
8.
Plessis, Christophe, Gurutze Arzamendi, José R. Leiza, et al.. (2001). Modeling of Seeded Semibatch Emulsion Polymerization of n-BA. Industrial & Engineering Chemistry Research. 40(18). 3883–3894. 105 indexed citations
9.
Plessis, Christophe, Gurutze Arzamendi, José R. Leiza, et al.. (2001). Kinetics and Polymer Microstructure of the Seeded Semibatch Emulsion Copolymerization of n-Butyl Acrylate and Styrene. Macromolecules. 34(15). 5147–5157. 91 indexed citations
10.
Charmot, Dominique, et al.. (2000). Controlled radical polymerization in dispersed media. Macromolecular Symposia. 150(1). 23–32. 183 indexed citations
12.
Shaw, Stephen, Paula Kavathas, Marilyn S. Pollack, Dominique Charmot, & Claude Mawas. (1981). Family studies define a new histocompatibility locus, SB, between HLA-DR and GLO. Nature. 293(5835). 745–747. 129 indexed citations
13.
14.
Sheehy, Michael J., Claude Mawas, & Dominique Charmot. (1979). Specific inhibition of human lymphocyte responses by primed autologous lymphocytes. I. Evaluation of MLR inhibition as a model for suppression.. PubMed. 122(6). 2198–203. 22 indexed citations
15.
Sheehy, Michael J., Claude Mawas, & Dominique Charmot. (1979). Specific Inhibition of Human Lymphocyte Responses by Primed Autologous Lymphocytes. The Journal of Immunology. 122(6). 2198–2203. 16 indexed citations
16.
Fradelizi, D, et al.. (1977). Cellular origin of cytotoxic effectors and secondary educated lymphocytes in human mixed leukocyte reaction. Cellular Immunology. 29(1). 6–15. 10 indexed citations
17.
Mawas, Claude, et al.. (1976). A Rapid HLA‐D Matching Method using PHA Blasts as Responding Cells (Preliminary Data on PHA Blasts HLA‐D Typing). Tissue Antigens. 8(4). 121–129. 1 indexed citations
18.
Mawas, Claude, et al.. (1976). Secondary response of in vitro-primed human lymphocytes to allogeneic cells. Immunogenetics. 3(1). 41–51. 9 indexed citations
19.
Fradelizi, D, et al.. (1976). Secondary response of in vitro-primed human lymphocytes to allogeneic cells. Immunogenetics. 3(1). 29–40. 26 indexed citations
20.
Buckingham, Margaret, A. Cohen, François Gros, et al.. (1975). Expression of the myosin gene in a hybrid cell derived from a rat myoblast and a mouse fibroblast. Biochimie. 56(11-12). 1571–1573. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026